Shanghai OPM Biosciences Co., Ltd. (SHA:688293)

Shanghai OPM Biosciences Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	737.06	891.14	1,282	1,506	310.34	309.19
Short-Term Investments	214.1	86.14	52.64	40.07	40.17	-
Trading Asset Securities	449.69	358.08	148.75	170.71	-	-
Cash & Short-Term Investments	1,401	1,335	1,484	1,717	350.51	309.19
Cash Growth	-2.05%	-9.99%	-13.57%	389.76%	13.37%	1066.22%
Accounts Receivable	105.5	110.85	96.35	76.81	41.75	39.3
Other Receivables	4.17	8.57	-	8.04	-	-
Receivables	109.67	119.42	96.35	84.85	41.75	39.3
Inventory	65.42	59.12	49.21	44.01	33.72	12.54
Prepaid Expenses	-	-	-	10.55	-	-
Other Current Assets	33.42	35.18	30.17	12.66	15.2	10.32
Total Current Assets	1,609	1,549	1,659	1,869	441.18	371.35
Property, Plant & Equipment	365.03	376.42	296.92	264.04	142.83	94.71
Long-Term Investments	107.98	264.58	239.73	143.73	68.09	70.08
Other Intangible Assets	37.1	37.68	39.21	40.33	42.46	-
Long-Term Deferred Tax Assets	3.58	3.58	2.08	0.84	0.13	-
Long-Term Deferred Charges	59.14	52.06	60.3	21.52	25.38	8.92
Other Long-Term Assets	125.49	2.84	4.43	8.53	27	8.01
Total Assets	2,308	2,286	2,302	2,348	747.08	553.07
Accounts Payable	67.06	62.8	37.46	21.31	13.75	11.33
Accrued Expenses	6.35	19.58	18.08	19.91	15.66	5.04
Short-Term Debt	-	-	-	20.02	40.04	15.02
Current Portion of Long-Term Debt	-	-	-	4.31	2.13	1.88
Current Portion of Leases	13.27	13.02	8.6	6.45	5.27	-
Current Income Taxes Payable	11.42	4.42	0.62	-	1.63	-
Current Unearned Revenue	12.43	15.57	4.28	16.04	16.62	1.41
Other Current Liabilities	7.89	4.03	1.6	1.21	0.72	2.34
Total Current Liabilities	118.42	119.42	70.65	89.26	95.82	37.02
Long-Term Debt	-	-	-	10.86	17.77	17.05
Long-Term Leases	50.47	52.32	60.79	50.15	56.51	-
Long-Term Unearned Revenue	26.41	17.89	12.18	12.54	14.53	5.02
Long-Term Deferred Tax Liabilities	1.33	1.33	0.59	0.26	-	-
Total Liabilities	196.63	190.97	144.21	163.07	184.62	59.08
Common Stock	113.55	114.77	114.77	81.98	61.49	61.49
Additional Paid-In Capital	1,856	1,904	1,899	1,925	428.34	420.27
Retained Earnings	143.25	128.58	158.74	178	72.63	12.23
Treasury Stock	-	-51	-13.75	-	-	-
Comprehensive Income & Other	0.23	0.24	0.19	0.12	-	-
Total Common Equity	2,113	2,097	2,159	2,185	562.45	493.99
Minority Interest	-1.58	-1.47	-0.78	-	-	-
Shareholders' Equity	2,111	2,095	2,158	2,185	562.45	493.99
Total Liabilities & Equity	2,308	2,286	2,302	2,348	747.08	553.07
Total Debt	63.74	65.34	69.39	91.8	121.72	33.95
Net Cash (Debt)	1,337	1,270	1,414	1,625	228.79	275.24
Net Cash Growth	-1.70%	-10.20%	-12.96%	610.20%	-16.88%	-
Net Cash Per Share	11.49	10.86	12.30	16.04	2.65	3.20
Filing Date Shares Outstanding	113.55	113.55	113.91	114.77	86.08	86.08
Total Common Shares Outstanding	113.55	113.55	114.53	114.77	86.08	86.08
Working Capital	1,491	1,430	1,589	1,780	345.36	334.33
Book Value Per Share	18.61	18.47	18.85	19.03	6.53	5.74
Tangible Book Value	2,076	2,059	2,119	2,144	519.99	493.99
Tangible Book Value Per Share	18.28	18.13	18.51	18.68	6.04	5.74
Buildings	-	63.8	63.8	63.8	27.17	-
Machinery	-	230.6	200.88	128.56	112.33	-
Construction In Progress	-	169.33	78.1	103.47	1.31	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.